Old Articles: <Older 7671-7680 Newer> |
|
The Motley Fool July 21, 2011 Arundhati Parmar |
New Hypertension Treatment from St. Jude Medical? St. Jude management is keeping mum on renal denervation. |
The Motley Fool July 20, 2011 Brian Orelli |
First in Class Isn't the Sweetest Position Bristol and AstraZeneca's diabetes drug dapagliflozin runs into trouble. |
IndustryWeek July 20, 2011 Adrienne Selko |
Pharmaceutical's Lean Prescription Facing increasing cost pressures, many pharmaceutical firms are finding a healthy dose of lean the perfect tonic. |
The Motley Fool July 20, 2011 Seth Jayson |
A Hidden Reason the Future Looks Bright for Kensey Nash The company may display positive inventory divergence, suggesting that management sees increased demand on the horizon. |
The Motley Fool July 20, 2011 Seth Jayson |
Why ArthroCare May Be About to Take Off How is ArthroCare doing by this quick checkup? At first glance, pretty well. |
The Motley Fool July 20, 2011 |
Quality Systems Earnings Preview Quality Systems will unveil its latest earnings on Monday, July 25. |
The Motley Fool July 20, 2011 |
Owens & Minor Earnings Preview Owens & Minor will unveil its latest earnings on Monday. |
The Motley Fool July 20, 2011 |
MWI Veterinary Supply Earnings Preview MWI Veterinary Supply will unveil its latest earnings Monday. |
The Motley Fool July 19, 2011 Cindy Johnson |
7 Health-Care Stocks Insiders Are Buying Folks in the know think these stocks will rise. Should you join them? |
The Motley Fool July 18, 2011 |
Healthways Earnings Preview Healthways will unveil its latest earnings Thursday. |
<Older 7671-7680 Newer> Return to current articles. |